GERN

Geron Corp
Data: 2026-07-02
$1.36
Price
7.09%
Change
$2.01
52W High
$1.04
52W Low

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Quick Stats
Jul 02, 2026

52.6

AI Score

HOLD

0.8

Volume Ratio

Aug 05, 2026

Next Earnings

12

+ve Days (30d)

14

-ve Days (30d)

GERN Stock Summary

Last updated Jul 02, 2026

GERN is currently trading at $1.36, positioned below its 200-day moving average of $1.39, suggesting bearish momentum. The stock has a 52-week range of $1.04 to $2.01.

Technical Analysis: The 50-day moving average stands at $1.33, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 58.668, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.181, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates GERN at 52.6/100 with a HOLD recommendation.

GERN (Geron Corp) Indicators

Last updated Jul 02, 2026

Indicator Value
RSI(14) 58.668
CMF (20) -0.181
ROC (10) 10.569
ADX (14) 23.626
Indicator Value
MACD (12,26,9) 0.008
AROONOSC (14) 64.286
WILLAMS %R (14) -31.429
MFI (14) 56.208
GERN Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

GERN Price vs Max Options Open Interest
GERN Max Change In Options Open Interest

GERN Options - Sort by Max open Interest (near term)

4th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

GERN Daily Out of Money Options - Sort by Max open Interest (near term)

4th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

GERN Daily In the Money Options - Sort by Max open Interest (near term)

4th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

GERN Most Active Options by Volume(near term)

4th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Geron Corp is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

GERN Moving Averages Analysis

Geron Corp has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 02, 2026

GERN (Geron Corp) Simple Moving Averages

Moving Averages are last updated Jul 02, 2026

Days MA
10 1.32
20 1.24
30 1.24
50 1.33
100 1.48
200 1.39

GERN Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 814.7 million
Earnings/Share ($) -0.11
Net Proft Margin (%) -0.3432
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.02
EPS Estimate Next Year ($) 0.065
WallStreet Target Price ($) 3.4
Most Recent Quarter